<?xml version="1.0" ?>
<document id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc">
  <chunk id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c0" text="Molecular Biology and Infection of Hepatitis E Virus">
    <entity charOffset="35-44" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c0.e0" ontology_id="DOID_2237" text="Hepatitis" type="disease"/>
    <entity charOffset="35-46" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c0.e1" ontology_id="DOID_4411" text="Hepatitis E" type="disease"/>
  </chunk>
  <chunk id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1" text="Hepatitis E virus (HEV) is a viral pathogen transmitted primarily via fecal-oral route. In humans, HEV mainly causes acute hepatitis and is responsible for large outbreaks of hepatitis across the world. The case fatality rate of HEV-induced hepatitis ranges from 0.5 to 3% in young adults and up to 30% in infected pregnant women. HEV strains infecting humans are classified into four genotypes. HEV strains from genotypes 3 and 4 are zoonotic, whereas those from genotypes 1 and 2 have no known animal reservoirs. Recently, notable progress has been accomplished for better understanding of HEV biology and infection, such as chronic HEV infection, in vitro cell culture system, quasienveloped HEV virions, functions of the HEV proteins, mechanism of HEV antagonizing host innate immunity, HEV pathogenesis and vaccine development. However, further investigation on the cross-species HEV infection, host tropism, vaccine efficacy, and HEV-specific antiviral strategy is still needed. This review mainly focuses on molecular biology and infection of HEV and offers perspective new insight of this enigmatic virus.">
    <entity charOffset="0-9" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e0" ontology_id="DOID_2237" text="Hepatitis" type="disease"/>
    <entity charOffset="0-11" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e1" ontology_id="DOID_4411" text="Hepatitis E" type="disease"/>
    <entity charOffset="117-132" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e2" ontology_id="DOID_2237" text="acute hepatitis" type="disease"/>
    <entity charOffset="123-132" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e3" ontology_id="DOID_2237" text="hepatitis" type="disease"/>
    <entity charOffset="175-184" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e4" ontology_id="DOID_2237" text="hepatitis" type="disease"/>
    <entity charOffset="241-250" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e5" ontology_id="DOID_2237" text="hepatitis" type="disease"/>
    <entity charOffset="949-958" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e6" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <pair e1="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e0" e2="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e6" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.p0" relation="true"/>
    <pair e1="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e1" e2="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e6" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.p1" relation="true"/>
    <pair e1="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e2" e2="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e6" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.p2" relation="true"/>
    <pair e1="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e3" e2="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e6" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.p3" relation="true"/>
    <pair e1="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e4" e2="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e6" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.p4" relation="true"/>
    <pair e1="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e5" e2="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.e6" id="693a04c2c05485c6f19c6fc281ebf65dc4fe06dc.c1.p5" relation="true"/>
  </chunk>
</document>
